148 related articles for article (PubMed ID: 35771264)
21. Pharmacokinetics and safety of two Voriconazole formulations after intravenous infusion in two doses in healthy Chinese subjects.
Li X; Wang C; Shi P; Liu Y; Tao Y; Lin P; Li T; Hu H; Sun F; Liu S; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Mar; 24(1):14. PubMed ID: 36869387
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the bioequivalence and safety of liraglutide injection
Liu C; Xu H; Yuan F; Chen H; Sheng L; Chen W; Xie H; Xu H; Li X
Front Pharmacol; 2023; 14():1326865. PubMed ID: 38186650
[No Abstract] [Full Text] [Related]
23. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Li Q; Hao Z; Yu Y; Tang Y
Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and bioequivalence study of new S-1 capsule in Chinese cancer patients.
Chen Y; Jiang Y; Qu J; Wang Q; Bai Y; Shi J; Shi Y; Chen X; Yang N; Heng J; Li K
Eur J Pharm Sci; 2020 Aug; 151():105384. PubMed ID: 32470574
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.
Liu YM; Pu HH; Liu GY; Jia JY; Weng LP; Xu RJ; Li GX; Wang W; Zhang MQ; Lu C; Yu C
Clin Ther; 2010 Jul; 32(7):1396-407. PubMed ID: 20678686
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, safety, and bioequivalence of apixaban tablets in healthy Chinese subjects under fasting and fed conditions.
Luo HY; Yao ZJ; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Guan YQ; Gao LC
Int J Clin Pharmacol Ther; 2023 Mar; 61(3):129-138. PubMed ID: 36458443
[TBL] [Abstract][Full Text] [Related]
27. Comparison of scaled-average, population, and individual bioequivalence on 2 tablets of pitavastatin calcium: a 3-period, reference-replicated, crossover study in healthy Chinese volunteers.
Huang YH; Li ZQ; Pan GX; Li YF; Liu Y; Sun JX; Gu XF; Li N; Wang BH
Clin Ther; 2014 Sep; 36(9):1205-1216.e6. PubMed ID: 25234550
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic and bioequivalence study of emtricitabine/tenofovir disoproxil fumarate tablets in healthy Chinese subjects
.
Lu C; Yang Y; Zhang Q; Zhou R; Liu Z; Hu W
Int J Clin Pharmacol Ther; 2019 Dec; 57(12):623-632. PubMed ID: 31549623
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male volunteers.
Liu YM; Liu GY; Liu Y; Li SJ; Jia JY; Zhang MQ; Lu C; Zhang YM; Li XN; Yu C
Clin Ther; 2009 Aug; 31(8):1787-95. PubMed ID: 19808137
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics, bioequivalence and safety of two formulations of ticagrelor in healthy Chinese subjects: Effects of food.
Dong C; Zhang X; Zhang Y; Ouyang W; Peng D; Li X; Li D; Qin Q
Basic Clin Pharmacol Toxicol; 2023 Apr; 132(4):313-320. PubMed ID: 36617810
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of tofacitinib citrate bioequivalence based on pharmacokinetic parameters in healthy Chinese subjects.
Yu B; Wang X; Yang Y; Lu C; Hu W; Zhang X
Int J Clin Pharmacol Ther; 2021 Apr; 59(4):343-352. PubMed ID: 33433317
[TBL] [Abstract][Full Text] [Related]
32. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
[TBL] [Abstract][Full Text] [Related]
33. A Single-dose, Two-Period Crossover Bioequivalence Study Comparing Two Liraglutide Formulations in Healthy Chinese Subjects.
Feng S; Cai L; Wang X; Yu Q; Cai J; Hao W; Chen Z; Su X; Du C; Zou Q; Guo W; Du D; Hu F; Li F; Liu Y
Clin Pharmacol Drug Dev; 2023 Apr; 12(4):385-391. PubMed ID: 36648126
[TBL] [Abstract][Full Text] [Related]
34. Bioequivalence and Safety Assessment of 2 Formulations of Low-Dose Metformin Hydrochloride under Fasting Conditions in Healthy Chinese Participants: A Randomized Phase 1 Clinical Trial.
Sun ML; Xu XW; Liu C; Tong YX; Wei YL; Liu HJ; Zhang W; Wang XH
Clin Pharmacol Drug Dev; 2024 Mar; 13(3):307-314. PubMed ID: 38189592
[TBL] [Abstract][Full Text] [Related]
35. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.
Li C; Xu J; Zheng Y; Chen G; Wang J; Ma L; Qiao Y; Niu J; Wu M; Zhang H; Li X; Chen H; Zhu X; Liu C; Ding Y
Chem Pharm Bull (Tokyo); 2017 Jun; 65(6):524-529. PubMed ID: 28392509
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
37. A bioequivalence study of trifluridine/tipiracil tablets in Chinese metastatic colorectal cancer patients under fed conditions.
Su HC; Min J; Song Y; Liu LL; Liu LN; Zhang HL
Cancer Chemother Pharmacol; 2023 Feb; 91(2):167-177. PubMed ID: 36622402
[TBL] [Abstract][Full Text] [Related]
38. Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Zhai Y; Wu L; Zheng Y; Wu M; Huang Y; Huang Q; Shentu J; Zhao Q; Liu J
Drug Des Devel Ther; 2020; 14():3131-3142. PubMed ID: 32801649
[TBL] [Abstract][Full Text] [Related]
39. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.
Zhang Q; Tao Y; Zhu Y; Zhu D
Clin Ther; 2010 Jan; 32(1):171-8. PubMed ID: 20171422
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu Q; Wang X; Chen Q; Zou Y; Xu X; Li T; Yu C; Zhu F; Zhang KE; Jia J; Liu Y
Drug Des Devel Ther; 2020; 14():4221-4230. PubMed ID: 33116410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
